U.S. Physical Therapy (NYSE:USPH) EVP Sells $244,920.00 in Stock

U.S. Physical Therapy, Inc. (NYSE:USPH) EVP Richard Binstein sold 3,000 shares of the business’s stock in a transaction that occurred on Friday, March 6th. The stock was sold at an average price of $81.64, for a total transaction of $244,920.00. Following the sale, the executive vice president directly owned 24,867 shares in the company, valued at $2,030,141.88. The trade was a 10.77% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

U.S. Physical Therapy Stock Performance

Shares of U.S. Physical Therapy stock opened at $79.79 on Thursday. The stock has a market cap of $1.21 billion, a price-to-earnings ratio of 56.19, a P/E/G ratio of 2.02 and a beta of 1.30. U.S. Physical Therapy, Inc. has a twelve month low of $62.77 and a twelve month high of $93.50. The company’s fifty day moving average is $83.84 and its 200 day moving average is $82.27. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 0.32.

U.S. Physical Therapy (NYSE:USPH) last issued its quarterly earnings data on Thursday, February 26th. The company reported $0.67 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.67. The company had revenue of $202.73 million during the quarter, compared to the consensus estimate of $200.10 million. U.S. Physical Therapy had a return on equity of 8.75% and a net margin of 5.07%.The firm’s revenue was up 12.3% compared to the same quarter last year. During the same period last year, the company earned $0.51 earnings per share. Sell-side analysts forecast that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current year.

U.S. Physical Therapy Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 10th. Stockholders of record on Friday, March 13th will be paid a $0.46 dividend. The ex-dividend date of this dividend is Friday, March 13th. This represents a $1.84 dividend on an annualized basis and a dividend yield of 2.3%. This is an increase from U.S. Physical Therapy’s previous quarterly dividend of $0.45. U.S. Physical Therapy’s payout ratio is currently 126.76%.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in USPH. Allspring Global Investments Holdings LLC bought a new position in shares of U.S. Physical Therapy in the third quarter valued at approximately $845,000. Geode Capital Management LLC raised its position in U.S. Physical Therapy by 1.2% in the 2nd quarter. Geode Capital Management LLC now owns 352,923 shares of the company’s stock valued at $27,602,000 after buying an additional 4,306 shares during the last quarter. JPMorgan Chase & Co. lifted its stake in U.S. Physical Therapy by 106.9% during the 3rd quarter. JPMorgan Chase & Co. now owns 109,837 shares of the company’s stock valued at $9,331,000 after acquiring an additional 56,752 shares in the last quarter. Bank of New York Mellon Corp boosted its holdings in U.S. Physical Therapy by 4.9% during the 2nd quarter. Bank of New York Mellon Corp now owns 131,556 shares of the company’s stock worth $10,288,000 after acquiring an additional 6,190 shares during the last quarter. Finally, CenterBook Partners LP grew its stake in shares of U.S. Physical Therapy by 189.0% in the 2nd quarter. CenterBook Partners LP now owns 47,014 shares of the company’s stock worth $3,676,000 after acquiring an additional 30,746 shares in the last quarter.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on the stock. Citigroup restated a “market outperform” rating on shares of U.S. Physical Therapy in a report on Monday, December 15th. Weiss Ratings restated a “hold (c)” rating on shares of U.S. Physical Therapy in a research report on Wednesday, January 21st. JPMorgan Chase & Co. decreased their target price on U.S. Physical Therapy from $110.00 to $100.00 and set an “overweight” rating for the company in a research note on Monday, November 24th. Barrington Research reiterated an “outperform” rating and issued a $103.00 target price on shares of U.S. Physical Therapy in a report on Friday, February 20th. Finally, Jefferies Financial Group started coverage on shares of U.S. Physical Therapy in a research report on Monday. They set a “buy” rating and a $102.00 price objective for the company. Five equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $104.50.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.